Patents by Inventor Shawn Langer

Shawn Langer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210310051
    Abstract: In one embodiment, the present invention provides a method for characterizing a first composition comprising a fecal-derived bacterial population, comprising the steps of: obtaining a live culture of the first composition comprising a fecal-derived bacterial population, supplying factors that selectively expand the at least one bacterial strain at a level below a threshold for detection above the threshold level by seeding a chemostat containing culture medium with a second composition comprising a fecal-derived bacterial population; adding the live culture of the first composition comprising a fecal-derived bacterial population to the seeded chemostat, and culturing the first composition comprising a fecal-derived bacterial population with the second composition comprising a fecal-derived bacterial population in the chemostat for a time sufficient to expand the at least one bacterial strain; removing a sample of the chemostat culture; and identifying the at least one bacterial strain.
    Type: Application
    Filed: February 10, 2017
    Publication date: October 7, 2021
    Inventors: Emma Allen-Vercoe, Shawn Langer, Nissim Mashiach
  • Patent number: 11098377
    Abstract: A method includes reconstituting a lyophilized microbial community. Ribonucleic acid (RNA) is extracted from at least one targeted microbe in the reconstituted microbial community at a plurality of selected time periods. The RNA as extracted at the selected time period is subjected to a multiplex analyzer and determining RNA concentrations at the plurality of selected time periods. An increase in the RNA concentration from a first of the plurality of selected time periods to a second of the plurality of time periods indicates RNA expression from the at least one targeted microbe. RNA expression from the at least one targeted microbe indicates that the at least one targeted microbe is a living microbe.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: August 24, 2021
    Assignee: NUBIYOTA LLC
    Inventors: Emma Allen-Vercoe, Kyla Cochrane, Shawn Langer